Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular C

来源 :临床与转化肝病杂志(英文版) | 被引量 : 0次 | 上传用户:mantou119119
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background and Aims: The relationship between quanti-tative magnetic resonance imaging (MRI) imaging features and gene-expression signatures associated with the recur-rence of hepatocellular carcinoma (HCC) is not well studied. Methods: In this study, we generated multivariable regres-sion models to explore the correlation between the preoper-ative MRI features and Golgi membrane protein 1 (GOLM1), SET domain containing 7 (SETD7), and Rho family GTPase 1 (RND1) gene expression levels in a cohort study including 92 early-stage HCC patients. A total of 307 imaging features of tumor texture and shape were computed from T2-weighted MRI. The key MRI features were identified by performing a multi-step feature selection procedure including the cor-relation analysis and the application of RELIEFF algorithm. Afterward, regression models were generated using kernel-based support vector machines with 5-fold cross-validation. Results: The features computed from higher specificity MRI better described GOLM1 and RND1 gene-expression levels, while imaging features computed from lower specificity MRI data were more descriptive for the SETD7 gene. The GOLM1 regression model generated with three features demon-strated a moderate positive correlation (p<0.001), and the RND1 model developed with five variables was positively as-sociated (p<0.001) with gene expression levels. Moreover, RND1 regression model integrating four features was mod-erately correlated with expressed RND1 levels (p<0.001). Conclusions: The results demonstrated that MRI radiomics features could help quantify GOLM1, SETD7, and RND1 ex-pression levels noninvasively and predict the recurrence risk for early-stage HCC patients.
其他文献
Background and Aims: LPAR6 is the most recently deter-mined G protein-coupled receptor of lysophosphatidic acid, and hardly any study has demonstrated the performance of LPAR6 in cancers. We sought to clarify the relationship of LPAR6 to prognosis potenti
儿童急性肝衰竭(acute liver failure, ALF)常常危及生命,且病因复杂,目前仍约一半的ALF原因未明。随着近几年精准医学的发展,国内外陆续报道了神经母细胞瘤扩增序列(Neuroblastoma amplified sequence, NBAS)基因突变导致的与发热相关的反复肝功能衰竭,被称为婴幼儿肝功能衰竭2型(infant liver failure syndrome 2, ILFS 2)。ILFS 2是一种罕见的疾病,其特征是发热引起的复发性急性肝功能衰竭或肝酶异常,对进展迅速的病
期刊
Background and Aims: This study aimed to evaluate the diagnostic performance of high frame rate contrast-en-hanced ultrasound (H-CEUS) of focal liver lesions (FLLs). Methods: From July 2017 to June 2019, conventional con-trast-enhanced ultrasound (C-CEUS)
A new definition of metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed in 2020. The change from nonalcoholic fatty liver disease (NAFLD) to MAFLD highlights the metabolic abnormalities that accompany fatty liver. The diagnosis of MA
To the Editor,rnWe read with great interest the article by Yu et al.1 who reported that the metabolic dysfunction-associated fatty liver disease (MAFLD) criteria are more practical and im-prove the identification of high-risk patients with fatty liver dis
期刊
Background and Aims: Liver enzyme abnormalities in coronavirus 2019 (COVID-19) are being addressed in the literature. The predictive risk of elevated liver enzymes has not been established for COVID-19 mortality. In this study, we hypothesized that elevat
Background and Aims: For high morbidity and mortality, hepatocellular carcinoma (HCC) becomes a major health issue worldwide. Nowadays, numerous non-coding RNAs (ncRNAs) are known to regulate the occurrence and patho-genesis of tumors. Some ncRNAs have al
Background and Aims: Perivascular epithelioid cell neo-plasms (PEComas) are a rare type of mesenchymal neo-plasm and their preoperative diagnosis is challenging. In this study, we summarized the experience from a single medical center to study the examina
The prevalence of metabolic (dysfunction)-associated fatty liver disease (MAFLD) is rapidly increasing and affects up to two billion individuals globally, and this has also resulted in increased risks for cirrhosis, hepatocellular carcinoma, and liver tra
目标温度管理(target temperature management, TTM)应用于临床已经有20年的历史,是目前唯一被指南推荐用于心脏骤停患者脑保护的干预措施,但是关于最佳目标温度,仍然存在很多争议。2021年6月,TTM-2研究结果公布,该研究是目前关于心脏骤停样本量最大的RCT研究,共入选1 850例院外心脏骤停患者(out of hospital cardiac arrest, OHCA)患者,随机分为低温组(目标温度33 ℃)和常温组(体温>37.8 ℃时积极处理发热),结果发现与常温相比
期刊